Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.51% vs -1.81% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 64.38% vs 170.00% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 29.97% vs 156.68% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -18.97% vs 16.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Guizhou Xinbang Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.51% vs -1.81% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -4.17% vs -11.29% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 64.38% vs 170.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 11.17% vs -38.17% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 29.97% vs 156.68% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 3.55% vs -27.32% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -18.97% vs 16.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -20.34% vs -23.38% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






